Table 2.
The number of FOXP3+ cells in different LCH tissues (x̅ ± s)
| Group | Patients | Number of CD3+ | Number of FOXP3+ | FOXP3+/CD3+ (%) |
|---|---|---|---|---|
| Skin LCH | 7 | 159 ± 88.55 | 49.14 ± 30.98 | 30.20 ± 8.75* |
| Normal skin | 6 | 76.33 ± 12.26 | 7.17 ± 5.77 | 8.75 ± 5.46 |
| Lung LCH | 8 | 180.88 ± 31.66 | 41.63 ± 16.43 | 22.59 ± 7.03** |
| Bronchiectasis | 6 | 70.83 ± 67.19 | 7.33 ± 8.73 | 8.00 ± 4.89 |
| Bone LCH | 3 | 157.33 ± 24.11 | 38.00 ± 14.73 | 24.03 ± 8.46*** |
| Plasmacell myeloma | 3 | 123.33 ± 15.27 | 3.67 ± 1.53 | 2.90 ± 0.96 |
*
P < 0.01 vs. normal skin;
**
P < 0.01 vs. bronchiectasis;
***
P < 0.05 vs. Plasmacell myeloma.